← Back to directory

Paul D. Robbins

Researcher Next ID · RN-021294

Researcher · Biochemistry, Genetics and Molecular Biology

University of Copenhagen

Copenhagen, Denmark

Not currently recruitingFunding unknown
Works count
857
Citation count
75,578
H-index
125
i10-index
477

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Virus-based gene therapy research
RNA Interference and Gene Delivery
Immunotherapy and Immune Responses
CAR-T cell therapy research
Telomeres, Telomerase, and Senescence

Publications

  • Guidelines for minimal information on cellular senescence experimentation in vivo

    Cell · 2024 · 10.1016/j.cell.2024.05.059

  • A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues

    Nature Communications · 2022 · 10.1038/s41467-022-32552-1

  • Targeting cellular senescence with senotherapeutics: senolytics and senomorphics

    FEBS Journal · 2022 · 10.1111/febs.16350

  • Cellular senescence: a key therapeutic target in aging and diseases

    Journal of Clinical Investigation · 2022 · 10.1172/jci158450

  • An aged immune system drives senescence and ageing of solid organs

    Nature · 2021 · 10.1038/s41586-021-03547-7

  • Cellular Senescence: Defining a Path Forward

    Cell · 2019 · https://doi.org/10.1016/j.cell.2019.10.005

  • Senolytics improve physical function and increase lifespan in old age

    Nature Medicine · 2018 · https://doi.org/10.1038/s41591-018-0092-9

  • Fisetin is a senotherapeutic that extends health and lifespan

    EBioMedicine · 2018 · 10.1016/j.ebiom.2018.09.015

  • New agents that target senescent cells: the flavone, fisetin, and the BCL-XL inhibitors, A1331852 and A1155463

    Aging · 2017 · 10.18632/aging.101202

  • Cellular senescence mediates fibrotic pulmonary disease

    Nature Communications · 2017 · https://doi.org/10.1038/ncomms14532

  • Identification of HSP90 inhibitors as a novel class of senolytics

    Nature Communications · 2017 · 10.1038/s41467-017-00314-z

  • The Clinical Potential of Senolytic Drugs

    Journal of the American Geriatrics Society · 2017 · 10.1111/jgs.14969

  • Identification of a novel senolytic agent, navitoclax, targeting the Bcl‐2 family of anti‐apoptotic factors

    Aging Cell · 2015 · 10.1111/acel.12445

  • The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

    Aging Cell · 2015 · https://doi.org/10.1111/acel.12344

  • Regulation of immune responses by extracellular vesicles

    Nature reviews. Immunology · 2014 · https://doi.org/10.1038/nri3622

  • NF-κB inhibition delays DNA damage–induced senescence and aging in mice

    Journal of Clinical Investigation · 2012 · 10.1172/jci45785

  • SIRT1 Negatively Regulates the Mammalian Target of Rapamycin

    PLoS ONE · 2010 · 10.1371/journal.pone.0009199

  • Synovial fibroblasts spread rheumatoid arthritis to unaffected joints

    Nature Medicine · 2009 · https://doi.org/10.1038/nm.2050

  • Exosomes Derived from IL-10-Treated Dendritic Cells Can Suppress Inflammation and Collagen-Induced Arthritis

    The Journal of Immunology · 2005 · 10.4049/jimmunol.174.10.6440

  • A conserved XIAP-interaction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis

    Nature · 2001 · 10.1038/35065125

  • Negative regulation of the Apaf-1 apoptosome by Hsp70

    Nature Cell Biology · 2000 · 10.1038/35019510

  • Clonal Isolation of Muscle-Derived Cells Capable of Enhancing Muscle Regeneration and Bone Healing

    The Journal of Cell Biology · 2000 · 10.1083/jcb.150.5.1085

  • 1999 Volvo Award Winner in Basic Science Studies

    Spine · 1999 · 10.1097/00007632-199912010-00002

  • Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy

    The Journal of Cell Biology · 1998 · 10.1083/jcb.142.5.1257

  • In vivo suppression of early experimental osteoarthritis by interleukin‐1 receptor antagonist using gene therapy

    Arthritis & Rheumatism · 1997 · 10.1002/art.1780400604

Current projects

    No projects listed.